140 related articles for article (PubMed ID: 9043664)
21. Second harmonic generation detection of Ras conformational changes and discovery of a small molecule binder.
Donohue E; Khorsand S; Mercado G; Varney KM; Wilder PT; Yu W; MacKerell AD; Alexander P; Van QN; Moree B; Stephen AG; Weber DJ; Salafsky J; McCormick F
Proc Natl Acad Sci U S A; 2019 Aug; 116(35):17290-17297. PubMed ID: 31399543
[TBL] [Abstract][Full Text] [Related]
22. High frequency (139.5 GHz) electron paramagnetic resonance characterization of Mn(II)-H2(17)O interactions in GDP and GTP forms of p21 ras.
Bellew BF; Halkides CJ; Gerfen GJ; Griffin RG; Singel DJ
Biochemistry; 1996 Sep; 35(37):12186-93. PubMed ID: 8810926
[TBL] [Abstract][Full Text] [Related]
23. NMR
Sharma AK; Lee SJ; Rigby AC; Townson SA
Biomol NMR Assign; 2018 Oct; 12(2):269-272. PubMed ID: 29721757
[TBL] [Abstract][Full Text] [Related]
24. Time-resolved FTIR studies of the GTPase reaction of H-ras p21 reveal a key role for the beta-phosphate.
Cepus V; Scheidig AJ; Goody RS; Gerwert K
Biochemistry; 1998 Jul; 37(28):10263-71. PubMed ID: 9665734
[TBL] [Abstract][Full Text] [Related]
25. The binding of guanine nucleotide to N-ras p21--a phosphorous and proton magnetic resonance study.
Grand RJ; Levine BA; Byrd PJ; Gallimore PH
Oncogene; 1989 Mar; 4(3):355-61. PubMed ID: 2649849
[TBL] [Abstract][Full Text] [Related]
26. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
[TBL] [Abstract][Full Text] [Related]
27. Nucleotide binding and GTP hydrolysis by the 21-kDa product of the c-H-ras gene as monitored by proton-NMR spectroscopy.
Löw A; Sprinzl M; Limmer S
Eur J Biochem; 1993 Apr; 213(2):781-8. PubMed ID: 8386636
[TBL] [Abstract][Full Text] [Related]
28. Novel K-Ras G12C Switch-II Covalent Binders Destabilize Ras and Accelerate Nucleotide Exchange.
Nnadi CI; Jenkins ML; Gentile DR; Bateman LA; Zaidman D; Balius TE; Nomura DK; Burke JE; Shokat KM; London N
J Chem Inf Model; 2018 Feb; 58(2):464-471. PubMed ID: 29320178
[TBL] [Abstract][Full Text] [Related]
29. Raman difference studies of GDP and GTP binding to c-Harvey ras.
Wang JH; Xiao DG; Deng H; Webb MR; Callender R
Biochemistry; 1998 Aug; 37(31):11106-16. PubMed ID: 9693007
[TBL] [Abstract][Full Text] [Related]
30. Targeting a Novel KRAS Binding Site: Application of One-Component Stapling of Small (5-6-mer) Peptides.
Fumagalli G; Carbajo RJ; Nissink JWM; Tart J; Dou R; Thomas AP; Spring DR
J Med Chem; 2021 Dec; 64(23):17287-17303. PubMed ID: 34787423
[TBL] [Abstract][Full Text] [Related]
31. Three-dimensional structure of p21H-ras and its implications.
Wittinghofer F
Semin Cancer Biol; 1992 Aug; 3(4):189-98. PubMed ID: 1421163
[TBL] [Abstract][Full Text] [Related]
32. Protein structure determination by combining sparse NMR data with evolutionary couplings.
Tang Y; Huang YJ; Hopf TA; Sander C; Marks DS; Montelione GT
Nat Methods; 2015 Aug; 12(8):751-4. PubMed ID: 26121406
[TBL] [Abstract][Full Text] [Related]
33. Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).
Graf von Roedern E; Grams F; Brandstetter H; Moroder L
J Med Chem; 1998 Jan; 41(3):339-45. PubMed ID: 9464365
[TBL] [Abstract][Full Text] [Related]
34. Assignments of backbone ¹H, ¹³C and ¹⁵N resonances in H-Ras (1-166) complexed with GppNHp at physiological pH.
O'Connor C; Kovrigin EL
Biomol NMR Assign; 2012 Apr; 6(1):91-3. PubMed ID: 21814767
[TBL] [Abstract][Full Text] [Related]
35. [A peptide inhibitor of the binding site of oncoproteins of the p21ras family].
Mzareulov KD
Biofizika; 2005; 50(3):413-7. PubMed ID: 15977829
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the predicted structures of loops in the ras-SOS protein bound to a single ras-p21 protein with the crystallographically determined structures in SOS bound to two ras-p21 proteins.
Smith S; Hyde M; Pincus MR
Protein J; 2005 Aug; 24(6):391-8. PubMed ID: 16323045
[TBL] [Abstract][Full Text] [Related]
37. Conformational and dynamic differences between N-ras P21 bound to GTPgammaS and to GMPPNP as studied by NMR.
Hu JS; Redfield AG
Biochemistry; 1997 Apr; 36(16):5045-52. PubMed ID: 9125526
[TBL] [Abstract][Full Text] [Related]
38. Exploring the Lapse in Druggability: Sequence Analysis, Structural Dynamics and Binding Site Characterization of K-RasG12C Variant, a Feasible Oncotherapeutics Target.
Adeniji EA; Olotu FA; Soliman MES
Anticancer Agents Med Chem; 2018; 18(11):1540-1550. PubMed ID: 30019652
[TBL] [Abstract][Full Text] [Related]
39. A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligand.
Sun Q; Phan J; Friberg AR; Camper DV; Olejniczak ET; Fesik SW
J Biomol NMR; 2014 Sep; 60(1):11-4. PubMed ID: 25087006
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the active site of p21 ras by electron spin-echo envelope modulation spectroscopy with selective labeling: comparisons between GDP and GTP forms.
Halkides CJ; Farrar CT; Larsen RG; Redfield AG; Singel DJ
Biochemistry; 1994 Apr; 33(13):4019-35. PubMed ID: 8142406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
